PRKN and Hepatic fibrosis: Our results demonstrated that exogenously administered Alda‐1 can significantly attenuate liver fibrosis partly through up‐regulating the antioxidant Nrf2/HO‐1 pathway and activating Parkin‐related mitophagy.